Year: 2019

Geochemical Results Outline Large Arsenic and Gold Trend on the Moose River Anticline, 4 km Southwest of St Barbara’s Touquoy MineHALIFAX, Nova Scotia, Nov. 29, 2019 (GLOBE NEWSWIRE) — MegumaGold Corp. (CSE: NSAU, OTC: NSAUF, FWB: 2CM2) (“MegumaGold” or the “Company”) is pleased to announce additional soil geochemical results with elevated arsenic and gold values for its Touquoy West Project (“Touquoy West”). These results, combined with the results disclosed earlier by the Company (see our press release dated November 19, 2019), define large gold-arsenic anomalies trending along the west extension of the Moose River anticline which hosts St Barbara Ltd.’s open pit Touquoy Gold Mine. This anticline can be traced along an aeromagnetic trend that extends across MegumaGold’s Touquoy West holding and continues through the Touquoy Gold...

Q2 2019 Metoject™ unit market demand increased 115%1;Rasuvo™ unit market demand increased 15%2; andRupall™ unit market demand increased 66%3Medexus management to host conference call at 8:00 AM ET on Monday, December 2, 2019TORONTO and CHICAGO and MONTREAL, Nov. 29, 2019 (GLOBE NEWSWIRE) — Medexus Pharmaceuticals Inc. (the “Company” or “Medexus”) (TSXV: MDP, OTCQB: PDDPF) today provided a business update and announced its financial and operating results for the three- and six-month periods ended September 30, 2019.  All dollar amounts below are in Canadian dollars.Q2 2020 Financial highlights*:Revenue was $16.4 million compared to $3.4 million for the fiscal quarter ended September 30, 2018 (Q2 2019)Gross profit was $9.6 million compared to $1.9 million for Q2 2019Gross margin was 58.6% compared to 53.8% for Q2 2019Adjusted EBITDA**...

TORONTO, Nov. 29, 2019 (GLOBE NEWSWIRE) — Itafos (TSX VENTURE: IFOS) (the “Company”) reported today its Q3 2019 financial results and operational highlights. The Financial Statements and Management’s Discussion and Analysis for the quarter ended September 30, 2019 are available under the Company’s profile at www.sedar.com and under the Investors – Financial Statements page of the Company’s website, www.itafos.com. All dollar values referenced in this news release are unaudited amounts in thousands of US Dollars except as otherwise noted.Overall HighlightsFor the three months ended September 30, 2019, the Company’s overall highlights were as follows:experienced significant and continued downward pressure on fertilizer prices in key markets including North America and Brazil;continued strong operational and environmental, health and...

Highlights: 

PETALUMA, Calif., Nov. 29, 2019 (GLOBE NEWSWIRE) — Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA) today announced the closing of a public offering of 446,577 shares of common stock at a public offering price of $3.50 per share.The net proceeds to Sonoma Pharmaceuticals, Inc. from this offering are approximately $1.4 million after deducting the placement agent commissions and other estimated offering expenses payable by Sonoma.Sonoma Pharmaceuticals, Inc. intends to use the net proceeds from the offering for general working capital, especially to fund marketing and product development efforts.Dawson James Securities, Inc. acted as the lead placement agent and sole book runner.This offering was made pursuant to an effective shelf registration statement on Form S-3 (File No. 333-221477) previously filed with the Securities and Exchange...

TORONTO, Nov. 29, 2019 (GLOBE NEWSWIRE) — Jade Power Trust (“Jade Power” or the “Trust”) (TSXV:JPWR.UN) is pleased to announce that it has released its financial results for the three and nine months ended September 30, 2019. All amounts in this release are expressed in Canadian Dollars unless otherwise indicated.Highlights1Record energy generation of 30,572 megawatt hours (“MWh”) for the third quarter of 2019, representing an increase of 2,366 MWh or 8% on a year-over-year basis. Record energy generation of 115,270 MWh for the nine months ended September 30, 2019, representing an increase of 7,233 MWh or 7% on a year-over-year basis.Revenue of $4.0 million for the third quarter of 2019, representing an increase of 11% from $3.6 million in the third quarter of 2018.  Revenue of $13.0 million for the nine months ended September 30,...

VANCOUVER, British Columbia, Nov. 29, 2019 (GLOBE NEWSWIRE) — Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus” or the “Company”), a specialty pharmaceutical company with a focus on developing, advancing and promoting differentiated products, today reported financial results for the three months ended September 30, 2019 (“Q3 2019”) and associated Company developments. Unless otherwise noted, all figures are in Canadian currency.“Aequus has continued to advance the business in Q3, signing a key collaboration with Medicom Healthcare which adds a collection of market-ready ophthalmology products along with late-stage development assets to our growing ophthalmology franchise in Canada,” said Doug Janzen, Charmain and CEO of Aequus. “This collaboration with Medicom fits perfectly into our goals and vision for the franchise....

SAINT-MICHEL-DES-SAINTS, Québec, 29 nov. 2019 (GLOBE NEWSWIRE) — Le conseil d’administration de Nouveau Monde Graphite Inc. (« Nouveau Monde » ou « NMG ») (TSXV: NOU; OTCQX: NMGRF; Frankfurt: NM9) a octroyé 150 000 options d’achat d’actions à un membre de la direction, Madame Christina Lalli, directrice, relations avec les investisseurs.Ces options d’achat d’actions sont octroyées conformément aux termes et modalités du nouveau régime d’options d’achat d’actions de la Société. Chaque option d’achat d’actions permet à son détenteur de souscrire une action ordinaire de la Société par action ordinaire pour une durée de 5 ans à compter de la date d’octroi.À propos de Nouveau Monde GraphiteNouveau Monde Graphite a découvert en 2015 un gisement de graphite de haute qualité sur sa propriété Matawinie située à Saint-Michel-des-Saints, à...

Stockholm, November 29, 2019 – Anoto Group AB (publ) (”Anoto”) today announced that Anoto’s total number of shares and votes has increased with 13,095,970 shares and votes, respectively.The change refers to shares issued in November based on the authorization granted to the board of directors on the annual general meeting on May 17, 2019.As of November 29, 2019, the total number of shares and votes in Anoto amounts to 150,262,257 shares and votes, respectively.For further information, please contact:Joonhee Won, CEOFor more information about Anoto, please visit www.anoto.com or email ir@anoto.comAnoto Group AB (publ), Reg.No. 556532-3929, Flaggan 1165, SE-116 74 StockholmThis information is information that Anoto AB (publ) is obliged to make public pursuant to the Financial Instruments Trading Act. The information was submitted for publication,...

Stockholm, 29 november, 2019 – Anoto Group AB (publ) (”Anoto”) meddelade idag att det sammanlagda antalet aktier och röster i Anoto har ökat med 13 095 970 aktier respektive röster.Förändringen avser aktier som emitterats under november i enlighet med stöd av det bemyndigande styrelsen erhöll på årsstämman den 17 maj 2019.Det totala antalet aktier och röster i Anoto uppgår per den 29 november 2019 till 150 262 257 aktier respektive röster.För ytterligare information kontakta:Joonhee Won, VDFör mer information om Anoto, besök www.anoto.com eller email ir@anoto.comAnoto Group AB (publ), Reg.No. 556532-3929, Flaggan 1165, 116 74 StockholmDenna information är sådan information som Anoto Group AB (publ) är skyldigt att offentliggöra enligt lagen om handel med finansiella instrument. Informationen lämnades genom ovanstående kontaktpersons försorg...